In Ivory Coast, arterial hypertension is 20.4% prevalent, with a high mortality rate. However, proper use of antihypertensive drugs can reduce the risks of morbidity and mortality associated with the disease. The aim of this study was to determine the pattern of antihypertensive drugs in an urban population in Abidjan. To this end, a retrospective descriptive study was conducted. Data were collected from the consumption histories of several pharmacies in the Abobo commune of Abidjan between March and August 2020. Drugs available in pharmacies and containing one or more active ingredients in the ATC classification of antihypertensives were included. A total of 1082 sales of antihypertensives were recorded, with 53% of medicines containing a single molecule and 46% containing combinations of two molecules. Antihypertensives containing one active compound showed a high proportion of diuretics (28.7%), followed by calcium antagonists (20.35%) and beta-blockers (19.13%). The combination of ACE inhibitors and calcium antagonists was sold at 34.71%, with the combination of calcium antagonists/ACE inhibitors + diuretics (45.46%) in the two and three-molecule classes respectively. All in all, the study showed the patients were satisfied with the use of antihypertensives, with furosemide and the amlodipine/perindopril combination at the top of the list.
References
[1]
Dzudie, A., Kengne, A.P., Muna, W.F.T., Ba, H., Menanga, A., Kouam Kouam, C., et al. (2012) Prevalence, Awareness, Treatment and Control of Hypertension in a Self-Selected Sub-Saharan African Urban Population: A Cross-Sectional Study. BMJ Open, 2, e001217. https://doi.org/10.1136/bmjopen-2012-001217
[2]
Dagnoko, F.S.S. (2019) Etude des pratiques de dispensation des antihypertenseurs au niveau des officines privées de la commune I de Bamako en 2018. Thèse, Université des sciences des techniques et des technologies de Bamako.
[3]
ESC/ESH (2018) Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertesion of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Journal of Hypertension, 36, 1953-2041.
[4]
Weber, M.A., Schiffrin, E.L., White, W.B., Mann, S., Lindholm, L.H., Kenerson, J.G., et al. (2013) Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension. The Journal of Clinical Hypertension, 16, 14-26. https://doi.org/10.1111/jch.12237
[5]
Mars, B., Heron, J., Kessler, D., Davies, N.M., Martin, R.M., Thomas, K.H., et al. (2016) Influences on Antidepressant Prescribing Trends in the UK: 1995-2011. Social Psychiatry and Psychiatric Epidemiology, 52, 193-200. https://doi.org/10.1007/s00127-016-1306-4
[6]
Euloge, K.K., Daniel, E., Audrey, A., Florent, K.K., Justin, K.D.B., Benedict, B., et al. (2019) May Measurement Month 2017: An Analysis of Blood Pressure Screening Results in Cote d’Ivoire—Sub-Saharan Africa. European Heart Journal Supplements, 21, D47-D49. https://doi.org/10.1093/eurheartj/suz086
[7]
Ministry of Health and Public Hygiene (2014) Annual Report on the Health Situation 2016. https://www.caidp.ci/uploads/afbecb26267216966367847db65a1288.pdf
[8]
World Health Organization (2021) Anatomical Therapeutic Chemical (ATC) Classification. https://www.who.int/tools/atc-ddd-toolkit/atc-classification
[9]
Choukem, S.P., Kengne, A.P., Dehayem, Y.M., Simo, N.L. and Mbanya, J.C. (2007) Hypertension in People with Diabetes in Sub-Saharan Africa: Revealing the Hidden Face of the Iceberg. Diabetes Research and Clinical Practice, 77, 293-299. https://doi.org/10.1016/j.diabres.2006.11.007
[10]
Duhot, D., Hebbrecht, G., Lemercier, X. and Clerc P. (2008) Description des classes médicamenteuses et leurs associations utilisées par les médecins généralistes pour la prise en charge de l’HTA. Société française des médecins généralistes, 1-2.
[11]
Girerd, X., Hanon, O., Pannier, B., Vaïsse, B. and Mourad, J. (2013) Évolution dans l’usage des traitements antihypertenseurs en France entre 2002 et 2012: Enquêtes FLAHS. Annales de Cardiologie et d’Angéiologie, 62, 210-214. https://doi.org/10.1016/j.ancard.2013.04.011
[12]
Konin, C., Adoh, M., Coulibaly, I., Kramoh, E., Safou, M. and N’guetta, R. (2007) L’observance thérapeutique et ses facteurs chez l’hypertendu noir africain. Archives des maladies du cœur et des vaisseaux, 100, 630-634.
[13]
Atallah, A., Mourad, J., Inamo, J., Zouini, N., Mbou, P. and Girerd, X. (2007) Traitements médicamenteux et non médicamenteux chez l’hypertendu en Guadeloupe en 2005: Enquête PRETRAHGUAD. Annales de Cardiologie et d’Angéiologie, 56, 92-96. https://doi.org/10.1016/j.ancard.2006.09.001
[14]
Effo, E., Tia, E., Alliman, E., Irié-N’Guessan, G. and Kouakou-Siransy, G. (2023) Pharmacotherapy for High Blood Pressure at the Consultation Service of Abidjan Heart Institute (Côte d’Ivoire). Journal of Population and Therapeutics and Clinical Pharmacology, 30, 1912-1920. https://doi.org/10.53555/jptcp.v30i17.2686
[15]
Kjeldsen, S.E., Naditch-Brule, L., Perlini, S., Zidek, W. and Farsang, C. (2008) Increased Prevalence of Metabolic Syndrome in Uncontrolled Hypertension across Europe: The Global Cardiometabolic Risk Profile in Patients with Hypertension Disease Survey. Journal of Hypertension, 26, 2064-2070. https://doi.org/10.1097/hjh.0b013e32830c45c3
[16]
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., et al. (2013) 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertesion of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Journal of Hypertension, 31, 1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
[17]
Mills, K.T., Bundy, J.D., Kelly, T.N., Reed, J.E., Kearney, P.M., Reynolds, K., et al. (2016) Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries. Circulation, 134, 441-450. https://doi.org/10.1161/circulationaha.115.018912
[18]
Houenassi, M.D., David, D., Codjo, L.H., Attinsounon, A.C., Alassani, A., Ahoui, S. and Agbodande, A. (2016) Prise en charge des hypertendus dans la ville de Cotonou (Bénin) en 2011: Connaissances attitudes et pratiques des médecins généralistes. Cardiovascular Journal of Africa, 27, 72-76.
[19]
James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., et al. (2014) 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8). JAMA, 311, 507-520. https://doi.org/10.1001/jama.2013.284427
[20]
Maher, R.L., Hanlon, J. and Hajjar, E.R. (2013) Clinical Consequences of Polypharmacy in Elderly. Expert Opinion on Drug Safety, 13, 57-65. https://doi.org/10.1517/14740338.2013.827660
[21]
Ministère de la santé de la Lutte contre le SIDA (2019) Recueil des protocoles thérapeutiques nationaux des pathologies (RPTN). Organisation Mondiale de la Santé. 1-196.
[22]
Theodorou, M., Stafylas, P., Kourlaba, G., Kaitelidou, D., Maniadakis, N. and Papademetriou, V. (2012) Physicians’ Perceptions and Adherence to Guidelines for the Management of Hypertension: A National, Multicentre, Prospective Study. International Journal of Hypertension, 2012, Article ID: 503821. https://doi.org/10.1155/2012/503821
